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Summary (151/150 words) 
 
The complex relationship between obstructive sleep apnoea (OSA) and the brain is explored in this 
review. During the untreated apnoea/hypopnoea, intermittent hypoxia, reoxygenation and 
hyper/hypocapnia occur, in both adults and children, along with changes in cerebral blood flow and 
sleep fragmentation. They may in time result in cognitive deficits with functional consequences for 
work and school efficiency. 
The ability to assess how OSA affects cognition depends on the specificity and sensitivity of the 
tests, which are rarely developed specifically for OSA. In this review we discuss both the neural 
adaptive and maladaptive processes to hypoxemia. Their net result on cognitive and emotional 
performance depends on the stage of this dynamic process, effects on other body systems, 
cognitive reserve and the idiosyncratic susceptibility. The contribution of fragmented sleep and the 
disruption of sleep structure is also explored, with a focus on its effects at different times in the 
genesis of the disease. 
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1. Introduction 
Obstructive sleep apnea (OSA) is a highly prevalent, chronic multisystem disease that remains 
under recognised in the general population, despite the 20 years that have elapsed since the 
seminal prevalence report was published in 1994, and over 30 years since the acclaimed account of 
continuous positive airway pressure (CPAP) treatment 1-4. Recent epidemiological data suggests 
that there has been a 14-55% increase in the prevalence of OSA in the USA since the early 1990s.5 
Similar prevalence distribution figures have been noted in other countries and specific ethnic groups 
around the world, with clear overall male preponderance until menopause age in women.6-10 OSA is 
commonly associated with serious cardiovascular and metabolic co-morbidities, with systemic 
hypertension occuring in up to 50% of OSA patients.11, 12 Its strong associations with old-age and 
obesity, both of which are on the rise, underscore its important current and future public health 
implications11, 13. 
The syndromic constellation of effects of OSA on the brain merit particular attention and are the 
focus of this review. OSA is increasingly recognised as one of the potentially modifiable risk factors 
for dementia, especially in older adults14-16. Moreover, its role in seizure aggravation in epilepsy, 
several neuropsychiatric disorders and stroke has also been argued2.  The progressive changes in 
sleep quality and structure, along with changes in the cerebral blood flow, neurovascular and 
neurotransmitter changes, the cellular redox status and neural regulation in OSA patients may 
constitute a contributing factor to cognitive decline, also seen with healthy aging, but present to a 
much greater extent in neurodegenerative diseases1, 16-19.  
Reduced quality of life, excessive daytime sleepiness, labile interpersonal relationships, increased 
road traffic accidents and decreased work and school efficiency have all been reported in OSA 
patients, and they are not always reversed with treatment 20. Beneficial effects of treatment on 
cognitive performance (including vigilance and sleepiness) and neural injury in OSA (Figure 1) are, 
however, documented in recent meta-analyses 21, 22 and a meta review 23. Two recent studies also 
suggest beneficial effects of the CPAP therapy in minimally symptomatic, and older OSA patients, 
respectively 24, 25. The current dearth of fully effective treatments for the central nervous system 
sequelae of OSA is likely to be a reflection of, as yet poorly understood, intricate interplay of 
intermittent hypoxia, reoxygenation, hypercapnia, changes in cerebral blood flow 26, and sleep 
fragmentation that results from nocturnal episodes of complete or partial pharyngeal obstruction in 
OSA1, 27.  
In recent years, we and others have argued that both adaptive and maladaptive processes to 
hypoxemia occur in brains of OSA patients. Their overall net result depends on the stage of this 
dynamic process, effects on other body systems, cognitive reserve and the idiosyncratic 
susceptibility of each particular patient (for in depth reviews please refer to2, 15, 17, 27-31). This is 
important as different therapeutical approaches might benefit different stages and conversely might 
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aggravate damage in some patients2, 17, 28.  To date, the contribution of fragmented sleep to 
cognitive and emotional performance of OSA patients has been largely overlooked2. Also, the 
diversity of published studies make it difficult to delineate the impact of its interplay with ongoing 
neuroinflammatory processes and ischemic preconditioning2. This review will address this gap in the 
background of new clinical and translational findings, and to argue their contribution to the inherent 
complexity of the relationship between OSA and the brain.  
 
2. The myth and reality of impaired cognition in patients with sleep apnoea 
A broad range of psychological problems and neurocognitive impairments have over the years been 
more or less consistently associated with OSA23. Despite this fact, it has been recently argued that 
detailed analysis of important studies in the field allows for only a weak correlation between 
(subjective) cognitive complaints in patients with OSA and their objective cognitive functioning 32. 
This argument has already been used to highlight divergent results of subjective versus objective 
complaints in other medical populations, and several possible explanations for this in OSA patients 
have been suggested. For example, an insufficient specificity of current tests for deficits 
documented in OSA is evident and largely acknowledged. Currently used and validated objective 
tests for cognition are frequently designed to cater for deficits found in brain-injured patients and as 
such do not specifically assess impairments in OSA32. Similarly, it is accepted that testing provides 
only a snapshot of someone’s ability, and that it is unlikely that it accurately assesses those aspects 
of cognition of patients in OSA that are task dependent or time dependent. Hence it follows that, 
given the complex make up of neuropathology of OSA, it is likely that the snapshot value of a 
particular function or ability, assessed by cognitive tests, does not fully account for its fluctuation 
over time and various daytime requirements. Cognitive domains are not unitary constructs, and only 
the carefully deconstructed analysis of their different subcapacities and their vulnerabilities to a 
range of risks and protective factors specific to OSA can provide a more realistic assessment of 
someone’s deficits22. Similarly, a number of impairments may be secondary to other symptoms of 
OSA, such as sleepiness, or they can be a sign of psychological distress32, 33.  
Of note, non-pharmacological and some pharmacological treatments for OSA have been shown to 
improve cognitive outcomes in OSA patient subpopulations. Several meta-analyses suggest that 
CPAP treatment reduces sleepiness complaints and mood problems, and that it improves objective 
cognitive functioning in OSA patients21, 32, 34, 35.  Many questions regarding treatment with CPAP, 
most pivotal of which are who, when and for how long should receive this treatment, are still 
unclear. The full prescriptive protocols, likely in combination with other lifestyle and/or 
pharmacological approaches, might only be achieved once the full spectrum of neuropathology of 
OSA and its dynamic fingerprinting are understood.2, 27 For example even that the beneficial effect 
of CPAP on symptoms of sleepiness and quality of life in some patients appear to be obtained after 
only few days of treatment with a good adherence, the effects on other subjective and objective 
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cognitive symptoms are less well defined.36, 37 Two recent studies suggest that prolonged treatment 
might be required in some severe patients.38, 39 An almost complete recovery of white matter tracts 
pathology with associated significant improvement in memory, attention and executive functioning 
has been demonstrated in a recent study only following one year of a compliant treatment in severe 
OSA patients.38 The need for longer treatment with CPAP in elderly has also been suggested by 
findings of another small pilot study which has shown that treatment of severe OSA in Alzheimer’s 
patients (of mild to moderate severity) is associated with significantly slower cognitive decline over 
three years.39 Although less striking, limited evidence with drugs such as donepezil, physiostigmine, 
and fluticasone also points to better cognitive outcomes in treated patients40, 41. So far, subjective 
cognitive complaints have been largely ignored in randomised controlled trials of treatments for 
OSA patients. In line with recent findings, and given that subjective cognitive complaints are known 
to be linked to quality of life, work productivity and health care utilisation in the general population 
future studies should account for them 32.  
Some authors have also argued against a reductionist approach to OSA-induced brain injury, and 
point out that emerging research indicates that the relationship between disease severity and 
cognitive dysfunction is the product of a multitude of susceptibility and protective factors, of which 
sleep fragmentation, hypoxia and cognitive reserve are only three aspects2, 22, 27. Some other, 
commonly ignored, important factors are duration of disease, the role of the blood-brain barrier, 
hypertension, metabolic dysfunction, systemic inflammation, cerebral blood flow, and genetic 
vulnerability (e.g. apolipoprotein e4 genotype)22. 
In the face of ongoing polemics in the field, the majority of studies to date nonetheless agree on 
significant deficits in attention/vigilance, delayed long-term visual and verbal memory, 
visuospatial/constructional abilities and executive dysfunction in patients with OSA23, 42. Several 
associations have been recognised: the association between the worsening in global cognitive 
functioning and the severity of hypoxaemia, and the association between the attention and vigilance 
dysfunction and the degree of sleep fragmentation23. Consensus in the field is less strong on the 
effects of OSA on working memory and short-term memory23. Also, language ability and 
psychomotor functioning have been shown to be largely unaffected by OSA23 in some studies, 
whilst others have pointed to psychomotor slowing as the most vulnerable cognitive domains, and 
least responsive to the treatment with CPAP43. Similarly, several studies that have shown 
impairments in language abilities in severe OSA patients have disagreed on whether phonemic or 
semantic domains are those of highest impact. 44. Neurodevelopmental stages of adolescents and 
children with OSA appear to dictate higher risk for this deficit45.   
The functional neuroanatomy of OSA has been further highlighted in a study following 3 months of 
treatment with CPAP that demonstrated improved cognitive function in several domains that 
corresponded to grey matter volume increases in frontal and hippocampal regions46. Similarly, 
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another recent study has shown significant improvements involving memory, attention, and 
executive functioning that correlated to the white matter changes after 12 months of treatment with 
CPAP38. The majority of studies investigating treatments for OSA failed to account for incomplete 
reversal of reversal of tissue damage, or deficits in cognition, suggesting that initiation of a 
(prolonged) treatment might be needed as early as possible in disease process47-49.  
In children, perhaps unsurprisingly, the results of studies looking into the cognitive performance and 
effects of treatment in children with OSA are equally divergent50, 51. In a recent study of children with 
sleep disordered breathing (SDB), followed for four years, treatment led to improvements in several 
aspects of neurocognition, collectively categorised as performance IQ50. Performance IQ represents 
fluid intelligence that is reflective of incidental learning, and it describes one’s ability to adapt to new 
situations52. In this study, improvements were recorded in tasks associated with spatial visualisation, 
visuo-motor coordination, abstract thought and nonverbal fluid reasoning50. However, overall 
improvements in the academic ability or behaviour were less clear. Furthermore, worsening of 
verbal IQ, which, unlike performance IQ, is more likely to be affected by formal education and 
learning experiences, was noted in a treated group50. A definitive explanation for this finding was not 
provided, and no statistically significant association between the reduction in verbal IQ performance 
and treatment was demonstrated50. Conversely, another influential study where younger children 
with SDB were followed for 12 months of treatment, showed significant improvements in academic 
performance 51. The different neurodevelopmental ages of children, and different test parameters 
used, provide for a complex clinical data set, against which no finite conclusions can be drawn. 
Nonetheless, particular patterns and associations seem to be emerging from this and earlier work, 
amongst which the association between performance IQ and slow wave activity (SWA) during the 
non-rapid eye movement (nREM) sleep is perhaps the strongest one50, 53. In healthy adults, sleep 
progresses through nREM stages N1 through N3 followed by a period of REM sleep occurring 
approximately 60- 90 minutes into sleep54. It has been argued that cognitive improvements in 
treated OSA patients may reflect increased stability of brain activity during sleep, allowing for a 
crucial synaptic repair/maintenance to occur and counteracting toxic effects of arousal and hypoxic 
effects of OSA50, 55. This argument is concordant with findings showing that the neurochemical and 
gene environments of sleep and sleep activity patterns present crucial window periods during which 
the brain can restore cellular homeostasis, increase signal to noise ratio, and reinforce neuronal 
circuitry for subsequent cognitive processing demands18, 56, 57. 
 
3. “Cognitive and emotional” sleep of sleep apnoea 
Sleep and sleep deprivation alter molecular signalling pathways that regulate synaptic strength, 
plasticity-related gene expression and protein translation in a bidirectional manner57. Moreover, 
sleep deprivation can impair neuronal excitability, decrease myelination and lead to cellular 
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oxidative stress and misfolding of cellular proteins57, 58. The correlations between oxidative stress 
markers, sleepiness and the presence of affective symptoms in patients with sleep apnoea have 
been suggested by findings of an open, cross-sectional, and comparative clinical trial.59 Frequent 
brief awakenings, and ensuing fragmented sleep, have been shown to impact next day’s cognitive 
and emotional functioning, in a manner similar to that of total sleep deprivation15.  Several studies 
have also attempted to assess if OSA patients were more vulnerable to sleep-loss induced 
performance deficits, with special emphasis on driving performance variables, with varied results60-63 
From the practical point of view it is of major interest to develop reliable and practical bedside tests 
to help clinicians advise patients on their individual traffic accidents risks. A recent preliminary study 
has shown potentially promising data for a specific EEG biomarker of neurobehavioural impairment 
and sleepiness (also see61 ). Preclinical studies suggest that sleep fragmentation independently 
affects similar brain regions to those affected by the intermittent hypoxia 1. Also, clinical studies of 
the effects of sleep deprivation on cognition in the general population suggest comparable cognitive 
impairments to those seen in OSA 64. Frequent partial arousals during sleep in OSA patients 
contribute to abnormal sleep architecture and symptoms of excessive daytime somnolence1, 27. An 
independent association between excessive daytime somnolence and cognitive impairment has 
been demonstrated and several prospective studies have shown that excessive daytime 
somnolence is associated with an increased risk of cognitive decline and dementia14. In a 
prospective cohort study (The Honolulu-Asia Aging Study), lower nocturnal oxygenation and 
reduction in SWS nREM sleep were associated with the development of microinfarcts and brain 
atrophy65. Conversely, men with longer SWA sleep showed slower cognitive decline65.  
3.1 Cognitive sleep 
The relationship between OSA and its effect on selected sleep stages merits particular attention, 
given that each of the sleep stages with its attendant alterations in neurophysiology is associated 
with facilitation of important functional learning and memory processes18. In OSA patients, the 
proportion of stage N2 nREM sleep has been shown to increase, while proportions of  stages N1, 
N3 and REM sleep decrease 44. Limited experimental studies conducted to date have shown 
specific impairments of sleep-dependent consolidation for verbal declarative information in patients 
with OSA66. Furthermore, several recent clinical studies suggest disturbed spatiotemporal evolution 
of sleep spindles in patients with OSA during the night 67, 68.  
However, consequences of sleep fragmentation on sleep in OSA are not easy to assess, and 
dynamic analysis of sleep architecture is required in order to fully gauge the impact on sleep. For 
example, in one study of mild OSA, where sleep fragmentation was likely not of sufficient size to 
provide significant SWS (e.g. in N3 nREM) and REM sleep decreases, the exponential decay 
function of SWA  was demonstrated as significantly slower in patients compared to controls69. This 
was due to the more even distribution of SWA throughout the night. These results show that mild 
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sleep fragmentation can alter the dynamics of SWA, without decreasing significantly the amounts of 
SWS and REM sleep and emphasize the need to perform SWA decay analysis in sleep 
fragmentation disorders69. In the same study, a decrease of spindle activity was observed in N2 and 
N3 which was not attributed to an increase of SWA67, 69. Such a reduction in total spindle density 
has also been reported in sleep maintenance insomnia, and is likely to be related to sleep 
fragmentation.67-69 
More recently, an integrative framework for qualitative reorganisation of memory during sleep has 
been suggested70. The model proposed by Landmann and colleagues (2014) further builds on 
studies that have shown that sleep facilitates the abstraction of rules and the integration of 
knowledge into existing schemas during the nREM SWS56, 57, 70. REM sleep, on the other hand, 
benefits creativity that requires the disintegration of existing patterns70. Of note, both sleep stages 
are commonly reported as reduced/fragmented in OSA, and it is likely that some of the cognitive 
complaints and memory deficits described are partly acquired via this dysregulation.44, 71 In line with 
this argument, in one study that looked into the neurocognitive deficits in OSA, the number of 
microarousals during the night was shown as the best predictor of episodic memory deficit 72. 
Traditionally, obstructive events during nREM sleep have been viewed as associated with greater 
cognitive deficits or impaired quality of life, whilst REM sleep events have been shown to be 
associated with greater sympathetic activity, hypertension and cardiovascular instability in patients 
with OSA73 74. Recently, the role for fragmented REM sleep in spatial navigational memory in OSA 
patients has been addressed with a physiologically relevant stimulus75. During this study, patients 
spent two different nights in the laboratory, during which they performed timed trials, before and 
after sleep, on one of two unique 3D spatial mazes75. The normal consolidation of sleep was 
achieved with use of therapeutic CPAP throughout the first night, whereas during the second night 
CPAP was reduced only during the REM stages. Here, patients showed improvements in maze 
performance after a night of normal sleep, and those improvements were significantly reduced 
following a night of REM disruption without changes in psychomotor vigilance. Noted cognitive 
improvements were significantly positively correlated with the mean REM run duration across both 
sleep conditions75.  
Another recent model might be of interest from perspective of OSA-induced sleep deficits54. Here, it 
is proposed that, during SWA of nREM sleep, recovery of functionally interconnected networks 
occurs54. This model also stresses the importance of the appropriate spatiotemporal revolution of 
sleep spindles throughout nREM sleep54. Sleep spindles are taken to reflect tagging of those 
networks that have presumably obtained the necessary recovery for their inclusion in the selection 
process during subsequent sleep54. In turn, further excursions into REM sleep then allow for a safe 
“offline” reactivation54. This serves to check and to deselect fully recovered brain networks from 
further SWA cycles. Once the network specific and function dictated number of SWA cycles is 
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achieved, a presumed transition to wake occurs54. Regarding OSA-induced deficits, it could be 
argued that this model offers robust theoretical framework for the origins of the sense of excessive 
daytime sleepiness and of feeling unrefreshed in the morning by some OSA patients. According to 
this model, this might be due to the inability to augment nREM SWA and or REM sleep during the 
period of high waking demands. Moreover, in some OSA patients, reduction of REM sleep can lead 
to dissociation of REM traits to other sleep stages, further impacting on critical sleep windows for 
memory formation and consolidation18. Of particular note, several studies have now demonstrated 
that, if high homeostatic demands are not fully met during sleep, in the subsequent wake period, 
microsleeps can occur in highly active regions of the brain54. This can lead to concomitant disability 
for the function catered by that region54, 56. To which level this takes place in OSA patients, and 
whether this also contributes to attention/vigilance dysfunction and higher levels of traffic accidents 
noted for this patient group, is yet to be fully understood. Previously reported retarded SWA decay 
throughout the night in even mild OSA patients further supports the notion of non-restorative sleep 
in OSA 69 . 
Most recently, it has been demonstrated that the degree of atrophy in the medial prefrontal cortex 
(mPFC), the area also known to be independently affected by OSA (Figure 1) and known to be 
involved in the generation of slow waves, predicts the extent of impaired SWA in the elderly, and 
consequent impaired overnight episodic hippocampal memory consolidation (Figure 2a)19, 57. It has 
been proposed that, at a clinical level, improving SWA in older adults may represent a novel 
treatment for minimising cognitive decline in later life19. Similarly, it has been recently shown that 
older adults who express fewer prefrontal fast sleep spindles than younger adults, also exhibit a 
proportional impairment in hippocampal functioning during the subsequent wake periods, and with 
that impairment, a deficit in the ability to form new episodic memories76. Fast sleep spindles 
represent part of a coordinated nREM sleep-dependent memory mechanism, and it is thought that 
hippocampal sharp-wave ripples provide feedback excitation, which initiates neuroplasticity in 
spindle-activated cortical neurons57. Relative to slow sleep spindles, fast sleep spindle events are 
associated with greater hippocampal activation and greater hippocampal–cortical functional 
connectivity15, 76. Intriguingly, in a study of spindle frequency changes in OSA, it has been shown 
that OSA patients, unlike healthy controls,  persisted in displaying a significant proportion of slow 
spindles in frontal, central and parietal regions during the night, perhaps suggesting that 
deregulated spindle formation might be another contributory facet to cognitive complaints in OSA 
patients67. In another study, the sleep architecture of mild OSA patients showed a high degree of 
sleep fragmentation resulting in a different time course of SWA and a decreased sleep spindle index 
when compared to controls69. Taken together, these studies also further highlight the possible role 
for OSA brain injury in the acceleration, or even initiation, of cognitive decline (Figure 2a) in older 
adults, although the exact pathophysiology of this association remains elusive14-16, 77. 
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3.2 Emotional sleep  
A bidirectional relationship between sleep and emotional brain function is increasingly supported by 
findings of studies that further build on long-standing clinical observations of co-occurring mood and 
sleep disorders78. Perhaps then unsurprisingly, affective disorders, emotional lability and depression 
have all been reported as highly prevalent in individuals with OSA, with some studies reporting that 
up to 63% of individuals are affected despite considerable heterogeneity and a high risk of bias2, 79, 
80. Evidence from various studies is particularly suggestive of role for REM sleep in selective 
emotional memory processing and sleep-dependent emotional memory depotentiation (Figure 2b)78. 
Moreover, REM sleep is suggested to play a role in recalibrating the sensitivity and speciﬁcity of the 
brain’s response to emotional events on both ends of positive and negative spectrum78. This effect 
likely occurs at least partly as a results of modulation of noradrenergic brain stem activity and the 
responsive proﬁles of the amygdala and medial prefrontal cortex (mPFC), two regions critically 
involved in detecting emotional salience78. 
Of all psychiatric disorders, the evidence for increased prevalence of OSA is particularly strong for 
major depressive disorder and post-traumatic stress disorder (PTSD)80, 81, both independently 
associated with REM sleep disturbance. Even though the causal relationship between these 
affective disorders and OSA is unclear and is likely to be multifactorial, the potential sleep 
mechanics of their interaction is worthy of further consideration. PTSD is independently associated 
with decreases in the total time spent in REM sleep. It is also associated with marked fragmentation 
of REM sleep, indicative of arousal-related awakenings from REM sleep linked to adrenergic 
surges78. CPAP adherence has been shown to be reduced in veterans with PTSD and comorbid 
OSA80. Based on the current knowledge of OSA-induced sleep deficits, it can be argued that in 
PTSD patients with co-morbid OSA, the additive effect of sleep disturbance can further impair the 
quantity and quality of REM sleep in affected individuals. This would likely also impact on REM’s 
noradrenergic “housekeeping” function, as it has been shown that REM sleep reduces, and thus 
likely restores, concentrations of noradrenaline to baseline, allowing for optimal wakeful 
functioning78. More specifically, several studies suggest that quiescence of locus coeruleus activity, 
a brain stem structure and a source of noradrenergic input, during REM sleep throughout the night 
restores the appropriate next-day tonic/phasic response speciﬁcity within emotional salience 
network (e.g. locus coeruleus, amygdala, mPFC)78.  It is hence feasible that OSA induced REM 
fragmentation could further aggravate the hyperadrenergic state of some PTSD patients, and lead 
to decreased connectivity between the PFC and amygdala, and exaggerated amygdala reactivity78. 
The functional outcome may be an aggravated disease course and worse prognosis78. Of note, in a 
prospective study higher nocturnal oxygenation during REM sleep was associated with less gliosis 
and neuronal loss in the locus coeruleus65. Major depression, on the other hand, is associated with 
exaggerated REM sleep qualities and deficiency in monoamine activity78. The dual relationship 
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between two disorders has been suggested by findings of several studies77. Arguably, in some OSA 
patients fragmented REM sleep can precipitate a vicious cycle of impaired regulation and rebound 
REM augmentation. This, along with concomitant changes in neurotransmitter systems caused by 
hypoxemia, could further lead to reduced monoamine activity, increased negative rumination and 
ensuing depression in genetically predisposed individuals. Through its effects on REM sleep, co-
morbid OSA might also lead to dysfunctional consolidation and depotentiation of emotional memory 
from prior affective experiences78. It has been proposed that this may result in a condition of chronic 
anxiety within autobiographical memory networks (Figure 2b)78. In recent meta-analysis of 
randomized controlled trials of treatment of OSA, a significant improvement in depressive symptoms 
was reported79.   
Even though all above argued theoretical constructs of a bidirectional relationship between sleep in 
OSA and psychiatric disorders are indirectly strongly supported by animal and neuroimaging studies 
of sleep (also see78), their true mechanics are likely to be more complex.  
 
4. Neuroinflammation and ischaemic conditioning are two “Janus” faces of intermittent hypoxia  
Cognitive and emotional complaints of OSA patients are equally well explained by oxidative and 
neuroinflammatory effects of OSA on the emotional salience network 2, 27, 77. In OSA, repetitive 
occlusions of the upper airway lead to intermittent hypoxia and recurrent hypoxemia, typically 
characterized by short cycles of hypoxia and reoxygenation28. However, the patterns vary greatly 
across patients, and, depending on the idiosyncratic characteristics of each individual, the end 
results might be either adaptive or maladaptive28. More specifically, the outcome will also likely 
depend on the dynamic interplay between the specific type and amount of reactive oxygen/nitrogen 
species produced, their duration and frequency, the intracellular localization, and the 
microenvironmental antioxidant activity17. Additional interplay depends on factors such as the 
genetic makeup, nutrition and other lifestyle-related variables, all of which affect the redox status 
(also see17, 28). A variety of studies to date suggest that the severity of hypoxia, its duration, and 
cycle frequency, are fundamental determinants of outcomes (Figure 3a)82. For example, it has been 
generally acknowledged that short, mild, and lower cycle frequency may generate beneficial and 
adaptive responses in brain, such as ischemic preconditioning28. Conversely, chronic, moderate to 
severe, and high frequency intermittent hypoxia can induce maladaptive disruption of homeostatic 
mechanisms, leading to dysfunction and sterile neuroinflammation17, 28.  
Ischemic preconditioning represents a generalized adaptation to ischemia by a variety of cells 29, 83. 
In OSA, induction of ischemic preconditioning is thought to be due to the activation of several gene 
programs, including the hypoxia inducible factor-1, vascular endothelial growth factor, 
erythropoietin, atrial natriuretic peptide and brain derived neurotrophic factor 84, 85. Over the years, 
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various end-mechanisms and pathways have been shown to play a role, including those of long-
term facilitation of phrenic motor output, chemoreflex activation, vascular remodelling, neo-
angiogenesis, productive autophagy, reactive gliosis, various synaptic alterations, and modulation of 
adult hippocampal neurogenesis (Figure 4) 17, 86-90. CPAP treatment of OSA has been shown to 
partially reverse the damage in hippocampal regions, and to ameliorate some of the associated 
cognitive deficits, possibly also by modulating adult neurogenesis 46. In a recent neuroimaging 
study, co-existence of hypotrophic and hypertrophic changes in brains of OSA patients was taken to 
reflect the evolving nature of OSA-associated brain injury30. It was proposed that at any given time 
ongoing maladaptive neuroinflammatory processes likely exist alongside adaptive mechanisms of 
increased brain plasticity and ischemic preconditioning 30, 83, 91-93. As a corollary to these findings, in 
a recent study that compared the cognitive performance of patients with high and low hypoxemia 
after controlling for demographic factors and other aspects of OSA severity, an unexpected 
advantage of higher hypoxemia on memory was demonstrated in a carefully matched clinical 
cohort94.  
Another powerful central neuroprotective adaptive mechanism for ischemic events has been 
demonstrated following the activation of the intrinsic neurons of the cerebellar fastigial nucleus 95. 
Neurostimulation of these nuclei appears to provide ’protective’ reduced excitability of cortical 
neurons during subsequent ischemic episodes, and to lead to reduced immunoreactivity of cerebral 
microvessels2. The ‘compensatory’ entraining of cerebellum by hypertrophic hippocampi has been 
proposed to occur in some younger patients with mild OSA 30. Although there are no direct 
monosynaptic anatomical connections between hippocampi and cerebellum, their connectivity is 
thought to be important for the control of movement under states of heightened emotion, novel 
conditions, and for associative learning2. Failed adaptation of cerebellar networks to injury has been 
shown to lead to cognitive deficits and hyperactivity, distractibility, ruminative behaviours, dysphoria 
and depression in some patients2, 96. Several studies also suggest that, under certain conditions, 
intermittent hypoxia can increase immune defences without exacerbating inflammation17, 28. 
Moreover, in animals, short-lasting hypoxic exposures mimicking OSA have been associated with 
recruitment of bone-marrow derived pluripotent stem cells, which exhibited up-regulation of stem 
cell differentiation pathways, particularly involving central nervous development and angiogenesis28. 
The other side of the coin are maladaptive effects of intermittent hypoxia. These include 
neuroinflammation, and although the exact neurocellular sources for associated processes are still 
incompletely defined, activation of astroglia is likely to be important17, 31. In addition, the 
oligodendrocytes, myelin-producing cells of the CNS, have been shown to be selectively sensitive to 
hypoxia and sleep fragmentation97, 98. The subsequent loss of buffering functions can ultimately 
contribute to pathological processes, such as increased glial proliferation and microglial activation 
(Figure 3b)31. Astroglial and microglial cells play critical roles in regional blood flow regulation and 
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inflammatory processes in the brain, as well as critical coordination of bioenergetics through lactate 
transport31. Under normal conditions, microglia in the healthy CNS exhibit a surveillance phenotype 
that synthesizes and releases neuroprotective growth/trophic factors31. However, severe and 
prolonged hypoxia can activate microglia toward a toxic, pro-inflammatory phenotype that triggers 
pathology, including hippocampal apoptosis, impaired synaptic plasticity, and cognitive 
impairment31.  Neuroinflammation has been shown to independently raise the brain's sensitivity to 
stress, resulting in stress-related neuropsychiatric disorders, such as anxiety or depression99. 
Dynamic changes in transcription of inflammatory genes have been demonstrated following 
exposure to intermittent hypoxia, with most inflammatory markers increasing over time31. Increased 
prostaglandin E2 neural tissue concentrations have also been demonstrated in hippocampal and 
cortical regions accompanied by lipid peroxidation of polyunsaturated fatty acids31. Similarly, it has 
been shown that increased carbonylation and nitrosylation-induced oxidative injury emerges in 
susceptible brain regions and promotes increased excessive daytime somnolence17, 31. Recently, 
toll-like receptor 4 (TLR4) expression and activity has been demonstrated to be increased on 
monocytes of patients with OSA100. Similarly, ligands for TLR4 have been shown to be increased in 
the serum of children with OSA100. The microglia of the cortex and brainstem exhibit TLR4 
expression after chronic intermittent hypoxia where it is postulated to play region specific and 
differential (adaptive or maladaptive) role.100 This finding is of particular interest since TLR4 has also 
been strongly implicated in several inflammatory and neurodegenerative disorders, including 
vascular dementia and Alzheimer’s disease100. In keeping, in cognitively healthy adults, intermittent 
hypoxia has been correlated with increases in phosphorylated and total tau and amyloidᵝ1-42 
concentrations in cerebral spinal fluid, key components of Alzheimer’s pathology14. Similarly, 
cerebral amyloidogenesis and tau phosphorylation along with neuronal degeneration and axonal 
dysfunction have been demonstrated in cortex and brainstems of animals exposed to intermittent 
hypoxia15. Taken together, these findings support the role for neuroinflammatory processes in 
cognitive and emotional deficits of OSA patients. They further suggest a close association between 
hypoxemia induced maladaptive processes and dementia (Figure 4c). 
 
5. Conclusions and future directions 
The disruption of sleep physiology by OSA is an underappreciated factor, which, together with 
hypoxemia and other already recognized factors, may further aggravate age-related memory 
deficits15, 16, 19, 76. Clinically, this dynamic interplay also underscores numerous subjective and 
objective cognitive and emotional complaints in some patients77, 78. An understanding of the 
proportional impact of these factors, in each individual patient, is a major challenge, because they 
occur simultaneously and, in all likelihood, target similar neurocircuitry. They also probably share 
some end-stage adaptive and maladaptive cellular mechanisms1, 2. Persistent deficits, even after 
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prolonged treatment with CPAP in some patients, suggest that early detection of the CNS sequelae 
in OSA is vital, so that appropriate treatment is administered before irreversible atrophic and 
metabolic changes occur. However, the timing and the duration of treatment, and the optimal 
treatment population, are still unclear and should be addressed in future prospective randomised 
control studies. Studies reviewed here strongly suggest that tapping into the therapeutic potential of 
ischemic preconditioning, whilst working on ameliorating the acute and chronic effects of 
neuroinflammation, may offer legitimate new therapeutical targets in OSA14, 15, 17, 28, 31. Similarly, 
although they are in their infancy, studies of clinical approaches that target the sleep disturbance 
arm of this intricate equation advocate a significant future treatment intervention potential14, 16, 76.   
In conclusion, recent findings raise valid questions about the mechanics of associations between 
OSA and dementia, and further highlight the public health importance of detecting and targeting 
those at highest risk for cognitive decline.  
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Figure 1: Brain regions and mechanisms involved in sleep apnoea injury. The nocturnal 
episodes of complete or partial pharyngeal obstruction result in intermittent hypoxia and sleep 
fragmentation. Both intermittent hypoxia and sleep fragmentation can aggravate brain injury (red 
arrows) and cause hypotrophic changes in several brain regions shown. Ensuing neurophysiological 
and neurochemical changes can also manifest in cognitive and emotional deficits that can be 
ameliorated (white arrows), using treatment with the continuous positive airway pressure therapy 
(CPAP) and or ischaemic preconditioning. Adapted from 101  
Figure 2: The role for sleep in cognition and emotions. (a) Cognitive Sleep: sleep apnoea and 
ageing can independently cause grey matter atrophy in the prefrontal cortex. Atrophy can mediate 
the degree of slow wave activity (SWA) disruption, whilst SWA in turn can mediate the degree of 
impaired memory retention19. SWA activity disruption likely also leads to cellular stress58. (b) 
Emotional Sleep: Conceptual schematics of “the sleep to forget and sleep to remember” model are 
shown78. Over one or several nights and numerous repetitions of this REM mechanism, sleep 
transforms an emotional memory into a memory of an emotional event that is no longer emotional.  
Reproduced with permission and adapted58 from 19,58, 78. 
Figure 3: Adaptive and maladaptive processes induced by intermittent hypoxia. Conceptual 
presentation of the net effect of cycles of intermittent hypoxia, of varied length and frequency, over a 
period of time (minutes to days to weeks) (a). High doses still elicit neuroadaptive mechanisms, 
however the balance is shifted and maladaptive processes such as (b) neuroinflammation are likely 
to be instigated. Finding an optimal dose is key to developing effective treatment. Reproduced with 
permission from31. (c) Possible cascade of interactions between sleep apnoea and Alzheimer’s 
disease.  
Figure 4: Putative theoretical neuromechanisms behind plastic changes noted in clinical 
studies of sleep apnoea patients.  
Theta () is the archetypical rhythmic activity in the hippocampus, which runs from the dentate gyrus 
(DG)-to CA3/CA1-to entorhinal cortex 91. Hippocampal  is thought to modulate the functional 
properties of the cerebellum and to govern hippocampal neurogenesis 91. A decrease in  band 
occurs post apnoea and hypopnoea events in some sleep apnoea patients 102. CPAP normalises 
these EEG changes 103. ‘Hypofunctioning’ fornix likely alters DG neurogenesis and possibly also 
contributes to mild cognitive decline in OSA 104, 105. Reproduced with permission from 106,2.  
